PGR and cancer: Progesterone treatment does not seem to affect RANKL expression in human breast cancer cells that express progesterone receptors (PR+), indicating that the progesterone-mediated regulation of the mammary epithelium is limited to normal-expressing, and not extended to RANK-expressing, cancer cells.